Key result
Temporary MCS in ascending aortic surgery linked to ~5.2-fold higher in-hospital mortality.
Why the study?
Ascending aortic surgery carries high perioperative risk, and data on device-specific outcomes of temporary mechanical circulatory support (MCS) in this surgical population are limited.
Does temporary mechanical circulatory support affect in-hospital mortality and adverse outcomes in adults undergoing ascending aortic or aortic arch replacement?
Cohort (n=87,215)
Yes
Does temporary mechanical circulatory support affect in-hospital mortality and adverse outcomes in adults undergoing ascending aortic or aortic arch replacement?
Temporary mechanical circulatory support during ascending aortic surgery is associated with substantially increased odds of in-hospital mortality, acute kidney injury, and hospital charges, supporting selective, risk-based utilization.
Answers are grounded in this paper and cite their sources.
May warrant cautious, selective MCS deployment in ascending aortic surgery; leaves open causal effects and optimal strategies for prospective trials.
Background Ascending aortic surgery carries high perioperative risk, and device-specific outcomes of temporary mechanical circulatory support (MCS) is limited in this surgical population. Objectives To evaluate associations between temporary MCS strategies and in-hospital outcomes following ascending aortic surgery. Methods Adult hospitalizations undergoing ascending aortic or aortic arch replacement were identified using the 2019–2023 National Inpatient Sample. MCS was classified as none, intra-aortic balloon pump (IABP), temporary ventricular assist device (VAD), venoarterial extracorporeal membrane oxygenation (VA-ECMO), or multiple devices. Outcomes included mortality, stroke, acute kidney injury, and hospital charges. Survey-weighted multivariable regression adjusted for demographics, comorbidities, cardiogenic shock, mechanical ventilation, acute dissection, and concomitant cardiac procedures. The institutional review board determined this was not human-subjects research; informed consent was not required. Results Of 87 215 weighted hospitalizations involving ascending aortic surgery, 2705 (3.1%) involved temporary MCS. Compared with no MCS, each strategy was associated with higher adjusted odds of in-hospital mortality: IABP (adjusted odds ratio [aOR], 5.20; 95% CI, 3.65–7.40), VAD (aOR, 10.80; 95% CI, 5.29–22.06), VA-ECMO (aOR, 19.20; 95% CI, 11.61–31.75), and multiple devices (aOR, 21.89; 95% CI, 9.18–52.15). All strategies were associated with higher odds of acute kidney injury and higher hospital charges. Conclusions Temporary MCS during ascending aortic surgery was associated with higher in-hospital mortality, adverse events, and costs. These findings support selective, risk-based MCS use and underscore the need for further prospective studies distinguishing pre-emptive from rescue device placement.
No takes yet. Share an insight, caveat, or question.
Smith et al. (2026) conducted a cohort in Ascending aortic or aortic arch replacement (n=87,215). Temporary mechanical circulatory support (IABP, temporary VAD, VA-ECMO, or multiple devices) vs. No temporary mechanical circulatory support was evaluated on In-hospital mortality (OR 5.20, 95% CI 3.65-7.40). Temporary MCS in ascending aortic surgery was associated with higher in-hospital mortality vs no MCS.
Synapse has enriched 10 related papers. Consider them for comparative context: